Enriqueta274 Barrows492
=======================
Race:                Black
Ethnicity:           Non-Hispanic
Gender:              F
Age:                 DECEASED
Birth Date:          1965-06-16
Marital Status:      M
--------------------------------------------------------------------------------
ALLERGIES:
No Known Allergies
--------------------------------------------------------------------------------
ENCOUNTER
2020-05-23 : Encounter at HEBREW REHABILITATION CENTER : Encounter for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
Type: inpatient
   
   MEDICATIONS:
  2020-05-27 : Etoposide 100 MG Injection for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
  2020-05-27 : Cisplatin 50 MG Injection for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
  2020-05-26 : Etoposide 100 MG Injection for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
  2020-05-26 : Cisplatin 50 MG Injection for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
  2020-05-24 : Etoposide 100 MG Injection for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
  2020-05-24 : Cisplatin 50 MG Injection for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
  2020-05-23 : Etoposide 100 MG Injection for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
  2020-05-23 : Cisplatin 50 MG Injection for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
   
   CONDITIONS:
   
   CARE PLANS:
   
   REPORTS:
  2020-05-23 : Comprehensive metabolic 2000 panel - Serum or Plasma
           - Glucose [Mass/volume] in Blood           64.6 mg/dL
           - Urea nitrogen [Mass/volume] in Blood     18.0 mg/dL
           - Creatinine [Mass/volume] in Blood        3.0 mg/dL
           - Calcium [Mass/volume] in Blood           9.4 mg/dL
           - Sodium [Moles/volume] in Blood           141.0 mmol/L
           - Potassium [Moles/volume] in Blood        4.7 mmol/L
           - Chloride [Moles/volume] in Blood         103.9 mmol/L
           - Carbon dioxide, total [Moles/volume] in Blood 20.3 mmol/L
           - Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 23.7 mL/min
           - Protein [Mass/volume] in Serum or Plasma 7.4 g/dL
           - Albumin [Mass/volume] in Serum or Plasma 5.4 g/dL
           - Globulin [Mass/volume] in Serum by calculation 3.4 g/L
           - Bilirubin.total [Mass/volume] in Serum or Plasma 1.2 mg/dL
           - Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 57.0 U/L
           - Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 41.4 U/L
           - Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 20.0 U/L
  2020-05-23 : Urinalysis macro (dipstick) panel - Urine
           - Appearance of Urine                      Cloudy urine (finding) {nominal}
           - Odor of Urine                            Urine smell ammoniacal (finding) {nominal}
           - Clarity of Urine                         Translucent (qualifier value) {nominal}
           - Color of Urine                           Brown color (qualifier value) {nominal}
           - Glucose [Mass/volume] in Urine by Test strip 0.7 mg/dL
           - Glucose [Presence] in Urine by Test strip Urine glucose test = ++ (finding) {nominal}
           - Bilirubin.total [Mass/volume] in Urine by Test strip 0.5 mg/dL
           - Bilirubin.total [Presence] in Urine by Test strip Finding of bilirubin in urine (finding) {nominal}
           - Ketones [Mass/volume] in Urine by Test strip 10.0 mg/dL
           - Ketones [Presence] in Urine by Test strip Urine ketone test = +++ (finding) {nominal}
           - Specific gravity of Urine by Test strip  1.0 {nominal}
           - pH of Urine by Test strip                5.5 pH
           - Protein [Mass/volume] in Urine by Test strip 367.7 mg/dL
           - Protein [Presence] in Urine by Test strip Urine protein test = +++ (finding) {nominal}
           - Nitrite [Presence] in Urine by Test strip Urine nitrite negative (finding) {nominal}
           - Hemoglobin [Presence] in Urine by Test strip Urine blood test = negative (finding) {nominal}
           - Leukocyte esterase [Presence] in Urine by Test strip Urine leukocyte test negative (finding) {nominal}
  2020-05-23 : CBC panel - Blood by Automated count
           - Leukocytes [#/volume] in Blood by Automated count 4.7 10*3/uL
           - Erythrocytes [#/volume] in Blood by Automated count 5.4 10*6/uL
           - Hemoglobin [Mass/volume] in Blood        16.4 g/dL
           - Hematocrit [Volume Fraction] of Blood by Automated count 35.7 %
           - MCV [Entitic volume] by Automated count  94.7 fL
           - MCH [Entitic mass] by Automated count    31.4 pg
           - MCHC [Mass/volume] by Automated count    33.8 g/dL
           - Erythrocyte distribution width [Entitic volume] by Automated count 39.4 fL
           - Platelets [#/volume] in Blood by Automated count 193.0 10*3/uL
           - Platelet distribution width [Entitic volume] in Blood by Automated count 369.2 fL
           - Platelet mean volume [Entitic volume] in Blood by Automated count 12.0 fL
   
   OBSERVATIONS:
  2020-05-27 : Pain severity - 0-10 verbal numeric rating [Score] - Reported 8.0 {score}
  2020-05-26 : Pain severity - 0-10 verbal numeric rating [Score] - Reported 5.0 {score}
  2020-05-25 : Pain severity - 0-10 verbal numeric rating [Score] - Reported 8.0 {score}
  2020-05-23 : Pain severity - 0-10 verbal numeric rating [Score] - Reported 5.0 {score}
  2020-05-23 : Platelet mean volume [Entitic volume] in Blood by Automated count 12.0 fL
  2020-05-23 : Platelet distribution width [Entitic volume] in Blood by Automated count 369.2 fL
  2020-05-23 : Platelets [#/volume] in Blood by Automated count 193.0 10*3/uL
  2020-05-23 : Erythrocyte distribution width [Entitic volume] by Automated count 39.4 fL
  2020-05-23 : MCHC [Mass/volume] by Automated count    33.8 g/dL
  2020-05-23 : MCH [Entitic mass] by Automated count    31.4 pg
  2020-05-23 : MCV [Entitic volume] by Automated count  94.7 fL
  2020-05-23 : Hematocrit [Volume Fraction] of Blood by Automated count 35.7 %
  2020-05-23 : Hemoglobin [Mass/volume] in Blood        16.4 g/dL
  2020-05-23 : Erythrocytes [#/volume] in Blood by Automated count 5.4 10*6/uL
  2020-05-23 : Leukocytes [#/volume] in Blood by Automated count 4.7 10*3/uL
  2020-05-23 : Leukocyte esterase [Presence] in Urine by Test strip Urine leukocyte test negative (finding) {nominal}
  2020-05-23 : Hemoglobin [Presence] in Urine by Test strip Urine blood test = negative (finding) {nominal}
  2020-05-23 : Nitrite [Presence] in Urine by Test strip Urine nitrite negative (finding) {nominal}
  2020-05-23 : Protein [Presence] in Urine by Test strip Urine protein test = +++ (finding) {nominal}
  2020-05-23 : Protein [Mass/volume] in Urine by Test strip 367.7 mg/dL
  2020-05-23 : pH of Urine by Test strip                5.5 pH
  2020-05-23 : Specific gravity of Urine by Test strip  1.0 {nominal}
  2020-05-23 : Ketones [Presence] in Urine by Test strip Urine ketone test = +++ (finding) {nominal}
  2020-05-23 : Ketones [Mass/volume] in Urine by Test strip 10.0 mg/dL
  2020-05-23 : Bilirubin.total [Presence] in Urine by Test strip Finding of bilirubin in urine (finding) {nominal}
  2020-05-23 : Bilirubin.total [Mass/volume] in Urine by Test strip 0.5 mg/dL
  2020-05-23 : Glucose [Presence] in Urine by Test strip Urine glucose test = ++ (finding) {nominal}
  2020-05-23 : Glucose [Mass/volume] in Urine by Test strip 0.7 mg/dL
  2020-05-23 : Color of Urine                           Brown color (qualifier value) {nominal}
  2020-05-23 : Clarity of Urine                         Translucent (qualifier value) {nominal}
  2020-05-23 : Odor of Urine                            Urine smell ammoniacal (finding) {nominal}
  2020-05-23 : Appearance of Urine                      Cloudy urine (finding) {nominal}
  2020-05-23 : Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 20.0 U/L
  2020-05-23 : Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 41.4 U/L
  2020-05-23 : Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 57.0 U/L
  2020-05-23 : Bilirubin.total [Mass/volume] in Serum or Plasma 1.2 mg/dL
  2020-05-23 : Globulin [Mass/volume] in Serum by calculation 3.4 g/L
  2020-05-23 : Albumin [Mass/volume] in Serum or Plasma 5.4 g/dL
  2020-05-23 : Protein [Mass/volume] in Serum or Plasma 7.4 g/dL
  2020-05-23 : Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 23.7 mL/min
  2020-05-23 : Carbon dioxide, total [Moles/volume] in Blood 20.3 mmol/L
  2020-05-23 : Chloride [Moles/volume] in Blood         103.9 mmol/L
  2020-05-23 : Potassium [Moles/volume] in Blood        4.7 mmol/L
  2020-05-23 : Sodium [Moles/volume] in Blood           141.0 mmol/L
  2020-05-23 : Calcium [Mass/volume] in Blood           9.4 mg/dL
  2020-05-23 : Creatinine [Mass/volume] in Blood        3.0 mg/dL
  2020-05-23 : Urea nitrogen [Mass/volume] in Blood     18.0 mg/dL
  2020-05-23 : Glucose [Mass/volume] in Blood           64.6 mg/dL
   
   PROCEDURES:
  2020-05-27 : High resolution computed tomography of chest without contrast (procedure)
  2020-05-27 : Combined chemotherapy and radiation therapy (procedure) for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
  2020-05-27 : Hearing examination (procedure)
  2020-05-26 : Combined chemotherapy and radiation therapy (procedure) for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
  2020-05-26 : Hearing examination (procedure)
  2020-05-24 : Combined chemotherapy and radiation therapy (procedure) for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
  2020-05-24 : Hearing examination (procedure)
  2020-05-23 : Combined chemotherapy and radiation therapy (procedure) for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
  2020-05-23 : Hearing examination (procedure)
   
   IMMUNIZATIONS:
   
   IMAGING STUDIES:
  2020-05-27 : Computed Tomography, Thoracic structure (body structure)
   
--------------------------------------------------------------------------------
CONTINUING
   
   CONDITIONS:
  2020-03-18 : Full-time employment (finding)
  2019-03-13 : Stress (finding)
  2019-02-14 : History of renal transplant (situation)
  2018-10-31 : Limited social contact (finding)
  2016-05-18 : Victim of intimate partner abuse (finding)
  2016-01-11 : Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
  2016-01-08 : Small cell carcinoma of lung (disorder)
  2015-12-08 : Suspected lung cancer (situation)
  2008-12-24 : Proteinuria due to type 2 diabetes mellitus (disorder)
  2007-03-07 : Microalbuminuria due to type 2 diabetes mellitus (disorder)
  2005-05-11 : Disorder of kidney due to diabetes mellitus (disorder)
  2004-04-14 : Metabolic syndrome X (disorder)
  1997-10-29 : Body mass index 30+ - obesity (finding)
  1984-08-15 : Anemia (disorder)
  1984-08-15 : Prediabetes
  1983-08-10 : Received higher education (finding)
  1983-08-10 : Essential hypertension (disorder)
   
   MEDICATIONS:
  2020-03-18 + lisinopril 10 MG Oral Tablet for Essential hypertension (disorder)
  2020-03-18 + 24 HR tacrolimus 1 MG Extended Release Oral Tablet for History of renal transplant (situation)
  2020-03-18 + Hydrochlorothiazide 25 MG Oral Tablet for Essential hypertension (disorder)
  2020-03-18 + insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin] for Prediabetes
  1984-08-23 : Vitamin B12 5 MG/ML Injectable Solution
   
   CAREPLANS:
  2019-02-14 : Care plan (record artifact)
                         Activity: Transplantation of kidney regime (regime/therapy)
                         Activity: Post-surgical wound care (regime/therapy)
                         Activity: Renal function monitoring (regime/therapy)
                         Activity: Very low sodium diet (finding)
  2016-01-11 : Terminal care
                         Reason: Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
                         Activity: Comfort measures
                         Activity: Chronic pain control management
                         Activity: Cancer education
  2014-12-20 : Dialysis care plan (record artifact)
                         Activity: Low salt diet education (procedure)
                         Activity: Lower limb exercises (regime/therapy)
                         Activity: Diet education (procedure)
  1984-08-15 : Diabetes self management plan
                         Reason: Prediabetes
                         Activity: Diabetic diet
                         Activity: Exercise therapy
  1983-08-10 : Lifestyle education regarding hypertension
                         Reason: Essential hypertension (disorder)
                         Activity: Prescribed activity/exercise education
                         Activity: Counseling about alcohol consumption
                         Activity: Dietary approaches to stop hypertension diet
                         Activity: Smoking cessation education
   
--------------------------------------------------------------------------------
